Chemours (NYSE: CC) awards 7,182 stock units to board director

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Chemours Co director Pamela Fletcher received a grant of 7,182 shares of Common Stock on May 6, 2026, as a stock award. The shares were awarded at a price of $0.00 per share as compensation, not an open-market purchase.

The award represents stock units that will convert one-for-one into Chemours common stock upon her separation from service on the Board and includes deferred stock units and dividend equivalent units. After this grant, Fletcher directly holds a total of 32,382.9997 shares of Chemours common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Fletcher Pamela

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,182	$0.00	--

Holdings After Transaction: Common Stock — 32,383 shares (Direct, null)

Footnotes (1)

Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board. Includes deferred stock units and dividend equivalent units.

Key Figures

Stock units granted: 7,182 shares Award price: $0.00 per share Total shares after grant: 32,382.9997 shares

3 metrics

Stock units granted 7,182 shares Common Stock award on May 6, 2026

Award price $0.00 per share Grant/award acquisition, non-market transaction

Total shares after grant 32,382.9997 shares Direct Chemours Common Stock holdings post-transaction

Key Terms

stock units, deferred stock units, dividend equivalent units

3 terms

stock units financial

"Represents stock units that will convert one-for-one to Chemours common stock"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

deferred stock units financial

"Includes deferred stock units and dividend equivalent units."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

dividend equivalent units financial

"Includes deferred stock units and dividend equivalent units."

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

Form 4 Insider Transactions: What Each Field Means →

05/08/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fletcher Pamela

(Last)

(First)

(Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON

DELAWARE

19899

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/06/2026		A		7,182⁽¹⁾	A	$0	32,382.9997⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.

2. Includes deferred stock units and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Chemours (CC) director Pamela Fletcher report in this Form 4?

Pamela Fletcher reported receiving a grant of 7,182 Chemours common stock units as director compensation. These stock units were awarded at $0.00 per share and increase her direct holdings to 32,382.9997 shares following the transaction, according to the Form 4 disclosure and related footnotes.

Is Pamela Fletcher’s Chemours Form 4 transaction a stock purchase or a grant?

The Form 4 shows a stock grant, not a market purchase. The transaction code "A" and description indicate a grant, award, or other acquisition, with 7,182 stock units awarded at $0.00 per share as compensation for her role on the Chemours Board.

How many Chemours shares does Pamela Fletcher hold after this Form 4 transaction?

After the reported grant, Pamela Fletcher directly holds 32,382.9997 Chemours common shares. This total includes the newly awarded 7,182 stock units that will convert one-for-one into common stock upon her separation from service on the company’s Board of Directors.

What are the terms of the Chemours stock units granted to Pamela Fletcher?

The stock units granted to Pamela Fletcher will convert one-for-one into Chemours common stock when she separates from Board service. Footnotes state the holdings include deferred stock units and dividend equivalent units, meaning dividend-related amounts are credited as additional units tied to the same conversion terms.

Did Pamela Fletcher pay anything for the Chemours stock units she received?

No, Pamela Fletcher did not pay cash for these stock units. The Form 4 lists a transaction price per share of $0.00, confirming they were granted as compensation rather than bought in the open market, consistent with typical director equity award structures at public companies.